Cardiovascular adverse events associated with VEGFR 2-targeted inhibitor in patients with solid tumors: a meta-analysis of randomized controlled trials
31 August 2025 (10:15 - 11:00)
Organised by: 
About the speaker
Lanzhou University Second Hospital, Lanzhou (China)
6 More presentations in this session
Assistant Professor J. Wang (Singapore, SG)
Doctor H. Kuang (Chongqing, CN)
Mr E. Zulfaj (Gothenburg, SE)
Ms M. Eslami (Vienna, AT)
Access the full session
The Event
ESC Congress 2025
31 August 2025
10:15 CET
You may be interested in
Congress Session
Congress Session
